“TNBC I’m kinda wondering if enrollment slowed
Post# of 148177
The biggest problem with the mTNBC trial is that there are only two trial sites, one in San Fransisco and the other in Chicago. That puts a strain on travel for patients who are or may be immunocompromised. That is the major reason for slow enrollment. I’d hoped at the beginning of 2020 that trial sites for cancer would be expanded, but that has yet to happen.